Sanofi CEO Paul Hudson: We have one of the best growth profiles in all of Big Pharma

(4:24)

Sanofi CEO Paul Hudson on R\u0026D Day: We're going to be the world's leading immunology company

(7:37)

Sanofi CEO Paul Hudson on Q3 results: The modernization effort is starting to pay off

(6:27)

Sanofi CEO Paul Hudson: We've got perhaps the world's best immunology pipeline

(5:)

Sanofi CEO Paul Hudson on Q1 results: Hope to gather even more momentum later this year

(3:1econd)

Sanofi CEO on AI's Impact, Lung Disease Drug Clearance

(8:54)

Episode 3: Innovating for a Healthier Future with Sanofi's CEO

(8:34)

What's the 'New Sanofi' Like? Let CEO Paul Hudson Explain. | At Barron's

(19:37)

Legion Technologies Founder \u0026 CEO Sanish Mondkar

(27:33)

Sanofi's brand-love building strategy - Julie Van Ongevalle, EVP/Global Head CHC, Sanofi

(35:13)

Sanofi Long Term Plan Presentation

(51:47)

How Sanofi Created A Company-Wide AI Strategy

(5:37)

Sanofi Chief Digital Officer Emmanuel Frenehard on the company’s comprehensive approach to AI

(10:57)

Gilead CEO Daniel O'Day on new HIV prevention medicine: It's going to change the face of HIV

(5:25)

Latest Myeloma Updates from ASH 2024: Easy-to-Understand Insights for Patients and Care Partners

(1:36:31)

Sanofi chief on new partnership with OpenAI for AI-driven drug development

(4:1econd)

Healthcare sector poised for rebound in 2025

(5:22)

Sanofi in talks to sell 50% stake in consumer health business to US private equity firm

(1:39)

Teva CEO Talks Drug Pricing, Generics, Supply Shortages | Bloomberg Talks

(7:9)

Sanofi’s CEO on How Company Culture Can Thrive in a Distributed, Hybrid World

(32:36)

CEO Paul Hudson on Sanofi’s Bold New Strategy and “Snackable AI”

(3:13)

Sanofi CEO: We’re buying cancer-biotech firm Synthorx for $2.5 billion

(5:45)

Sanofi CEO Paul Hudson on Q3 results: Increased R\u0026D spending will impact 2024 profit

(7:26)

Special Interview | Sanofi to Become No 1 in Healthcare in KSA by End of 2024 CEO: Paul Hudson

(9:20)

Sanofi CEO Paul Hudson on the coronavirus, the FDA, drug development and more

(5:48)

Sanofi CEO: Real breakthrough in RSV treatment is 'right around the corner'

(4:3)

Sanofi CEO Paul Hudson on Q2 results: Our underlying growth is still high-single digit

(5:51)

Recordati CEO sees 'substantial opportunity' in Sanofi drug purchase

(3:47)

Sanofi CEO Paul Hudson on cancer research, Covid-19 vaccine and more

(4:13)